SIREN : 400020996
SOCIETE OCCITANE DE SANTE is a French company founded 31 years ago, specialized in the sector Activités des sociétés holding. Based in TOULOUSE (31400), this company of category PME shows in 2024 a revenue of 832 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 832 476 € | 792 028 € | 751 382 € | 719 172 € | 621 648 € | 564 657 € | 554 077 € | 544 093 € | 538 569 € |
| Net income | 2 942 810 € | 510 020 € | 211 666 € | 180 535 € | -93 153 € | 436 354 € | -527 765 € | 403 554 € | 1 762 924 € |
| EBITDA | 460 074 € | 411 124 € | 263 678 € | 255 250 € | 245 220 € | 259 735 € | 183 612 € | 303 264 € | 281 318 € |
| Net margin | 353.5% | 64.4% | 28.2% | 25.1% | -15.0% | 77.3% | -95.3% | 74.2% | 327.3% |
In 2024, SOCIETE OCCITANE DE SANTE achieves revenue of 832 k€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.6%. Vs 2023: +5%. After deducting consumption (0 €), gross margin stands at 832 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 460 k€, representing 55.3% of revenue. Positive scissor effect: EBITDA margin improves by +3.4 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 2.9 M€, i.e. 353.5% of revenue. This profit can be retained or distributed to shareholders.
832 476 €
832 476 €
460 074 €
153 985 €
2 942 810 €
55.3%
The debt ratio (= Financial debt / Equity x 100) stands at 128%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 4.7 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 438.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
128.448%
43.699%
438.569%
4.726
17.4%
In 2024, the debt ratio of SOCIETE OCCITANE DE SANTE (128.45) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of SOCIETE OCCITANE DE SANTE (43.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of SOCIETE OCCITANE DE SANTE (4.73) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 51326.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 92.0x. Operating income very largely covers interest expenses: high safety margin.
51326.638
91.995
In 2024, the liquidity ratio of SOCIETE OCCITANE DE SANTE (51326.64) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of SOCIETE OCCITANE DE SANTE (92.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 74 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 33 days. The gap of 41 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 1846 days of revenue, i.e. 4.3 M€ to permanently finance. Over 2016-2024, WCR increased by +58%, requiring additional financing.
4 269 869 €
74 j
33 j
0 j
1846 j
Based on 54 transactions of similar company sales
in 2024,
the value of SOCIETE OCCITANE DE SANTE is estimated at
2 118 744 €
(range 827 817€ - 6 487 489€).
With an EBITDA of 460 074€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SOCIETE OCCITANE DE SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of SOCIETE OCCITANE DE SANTE in 2024 is 832 k€.
Yes, SOCIETE OCCITANE DE SANTE generated a net profit of 2.9 M€ in 2024.
The headquarters of SOCIETE OCCITANE DE SANTE is located in TOULOUSE (31400), in the department Haute-Garonne.
The tax return of SOCIETE OCCITANE DE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SOCIETE OCCITANE DE SANTE operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.